Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
2(50.0%)
4Total
Phase 4(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05691062Phase 4Enrolling By Invitation

Titanium vs. PEEK Fusion Devices in 1 Level TLIF

Role: lead

NCT06820736Not ApplicableRecruiting

A Prospective, Randomized Comparison Of Drainage Techniques After One- Or Two-Level Open Posterior Lumbar Decompression Or Decompression And Fusion

Role: lead

NCT03745040Phase 4Suspended

Liposomal Bupivacaine in One-level Instrumented Posterior Spinal Fusion

Role: collaborator

NCT04097678Not ApplicableCompleted

Intraoperative Radiographic Detection of Retained Surgical Sponges

Role: lead

All 4 trials loaded